Navaneetha Nambigari
Cancer Therapeutics: Structure-Based Drug Design of Inhibitors for a Novel Angiogenic Growth Factor
Mathematical Biology & Bioinformatics. 2023;18(1):72-88.
doi: 10.17537/2023.18.72.
References
- Harris A.L. Angiogenesis as a New Target for Cancer Control. Eur. J. Cancer, Suppl. 2003;1(2):1–12. doi: 10.1016/S1359-6349(03)00007-7
- Gavalas N., Liontos M., Trachana S.P., Bagratuni T., Arapinis C., Liacos C., Dimopoulos M., Bamias A., Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer. Int. J. Mol. Sci. 2013;14(8):15885–15909. doi: 10.3390/ijms140815885
- Bergers G., Hanahan D. Modes of Resistance to Anti-Angiogenic Therapy. Nat. Rev. Cancer. 2008;8(8):592–603. doi: 10.1038/nrc2442
- Plate K.H., BreierG., Farrell C.L., Risau W. Platelet-Derived Growth Factor Receptor-Beta Is Induced Duringtumor Development and Upregulated during Tumor Progressionin Endothelial Cells in Human Gliomas. Lab. Invest. 1992;67:529–534.
- Yu J.H., Ustach C., ChoiKim H.R. Platelet-Derived Growth Factor Signaling and Human Cancer. BMB Rep. 2003;36(1):49–59. doi: 10.5483/BMBRep.2003.36.1.049
- Anderberg C., Li H., Fredriksson L., Andrae J., Betsholtz C., Li X., Eriksson U., Pietras K. Paracrine Signaling by Platelet-Derived Growth Factor-CC Promotes Tumor Growth by Recruitment of Cancer-Associated Fibroblasts. Cancer Res. 2009;69(1):369–378. doi: 10.1158/0008-5472.CAN-08-2724
- Crawford Y., Kasman I., Yu L., Zhong C., Wu X., Modrusan Z., Kaminker J., Ferrara N. PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment. Cancer Cell. 2009;15(1):21–34. doi: 10.1016/j.ccr.2008.12.004
- Reigstad L. J., Varhaug J. E.; Lillehaug, J. R. Structural and Functional Specificities of PDGF-C and PDGF-D, the Novel Members of the Platelet-Derived Growth Factors Family. FEBS J. 2005;272(22):5723–5741. doi: 10.1111/j.1742-4658.2005.04989.x
- Wågsäter D., Zhu C., Björck H. M., Eriksson P. Effects of PDGF-C and PDGF-D on Monocyte Migration and MMP-2 and MMP-9 Expression. Atherosclerosis. 2009;202(2):415–423. doi: 10.1016/j.atherosclerosis.2008.04.050
- Li X., Kumar A., ZhangF., Lee C., Li Y. Tang Z., Arjunan P. VEGF-Independent Angiogenic Pathways Induced by PDGF-C. Oncotarget. 2010;1(4):309–314. doi: 10.18632/oncotarget.141
- Risau W., Drexler H., Mironov V., Smits A., Siegbahn A., Funa K., Heldin C.-H. Platelet-Derived Growth Factor Is Angiogenic In Vivo. Growth Factors. 1992;7(4):261–266. doi: 10.3109/08977199209046408
- Zwerner J.P., May W.A. Dominant Negative PDGF-C Inhibits Growth of Ewing Family Tumor Cell Lines. Oncogene. 2002;21(24):3847–3854. doi: 10.1038/sj.onc.1205486
- Zwerner J.P,. May W.A. PDGF-C Is an EWS/FLI Induced Transforming Growth Factor in Ewing Family Tumors. Oncogene. 2001;20(5):626–633. doi: 10.1038/sj.onc.1204133
- Gilbertson D.G., Duff M.E., West J.W., Kelly J.D., Sheppard P.O., Hofstrand P.D., Gao Z., Shoemaker K., Bukowski T.R., Moore M., Feldhaus A.L., Humes J.M. Palmer T.E., Hart C.E. Platelet-Derived Growth Factor C (PDGF-C), a Novel Growth Factor That Binds to PDGF α and β Receptor. J. Biol. Chem. 2001;276(29):27406–27414. doi: 10.1074/jbc.M101056200
- Li X., Pontén A., Aase K., Karlsson L. Abramsson A., Uutela M., Bäckström G., Hellström M., Boström H., Li H., Soriano P., Betsholtz C., Heldin C.-H., Alitalo K., Östman A. Eriksson U. PDGF-C Is a New Protease-Activated Ligand for the PDGF α-Receptor. Nat. Cell Biol. 2000;2(5):302–309. doi: 10.1038/35010579
- Raica M., Cimpean A.M. Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy. Pharmaceuticals. 2010;3(3):572–599. doi: 10.3390/ph3030572
- Chothia C., Lesk A.M. The Relation between the Divergence of Sequence and Structure in Proteins. EMBO J. 1986;5(4):823–826. doi: 10.1002/j.1460-2075.1986.tb04288.x
- Martí-Renom M.A., Stuart A.C., Fiser A., Sánchez R., Melo F., Šali A. Comparative Protein Structure Modeling of Genes and Genomes. Annu. Rev. Biophys. Biomol. Struct. 2000;29(1):291–325. doi: 10.1146/annurev.biophys.29.1.291
- Altschul S. Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs. Nucleic Acids Res. 1997;25(17):3389–3402. doi: 10.1093/nar/25.17.3389
- Cole C,. Barber J.D., Barton G.J. The Jpred 3 Secondary Structure Prediction Server. Nucleic Acids Res. 2008;36:W197–W201. doi: 10.1093/nar/gkn238
- Contreras-Moreira B., Bates P.A. Domain Fishing: A First Step in Protein Comparative Modelling. Bioinformatics. 2002;18(8):1141–1142. doi: 10.1093/bioinformatics/18.8.1141
- Berman H.M. The Protein Data Bank. Nucleic Acids Res. 2000;28(1):235–242. doi: 10.1093/nar/28.1.235
- Gonnet G.H., Cohen M.A., Benner S.A. Exhaustive Matching of the Entire Protein Sequence Database. Science. 1992;256(5062):1443–1445. doi: 10.1126/science.1604319
- Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: Improving the Sensitivity of Progressive Multiple Sequence Alignment through Sequence Weighting, Position-Specific Gap Penalties and Weight Matrix Choice. Nucleic Acids Res. 1994;22(22):4673–4680. doi: 10.1093/nar/22.22.4673
- Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X Version 2.0. Bioinformatics. 2007;23(21):2947–2948. doi: 10.1093/bioinformatics/btm404
- Brooks B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S.K.M. CHARMM: A Program for Macromolecular Energy, Minimization, and Dynamics Calculations. J. Comput. Chem. 1983;4:187–217. doi: 10.1002/jcc.540040211
- Šali A., Potterton L., Yuan F., van Vlijmen H., Karplus M. Evaluation of Comparative Protein Modeling by MODELLER. Proteins Struct. Funct. Genet. 1995;23(3):318–326. doi: 10.1002/prot.340230306
- Šali A., Blundell T.L. Comparative Protein Modelling by Satisfaction of Spatial Restraints. J. Mol. Biol. 1993;234(3):779–815. doi: 10.1006/jmbi.1993.1626
- Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-Pdb Viewer: An Environment for Comparative Protein Modeling. Electrophoresis. 1997;18(15):2714–2723. doi: 10.1002/elps.1150181505
- Fiser A., Do R.K.G., Šali A. Modeling of Loops in Protein Structures. Protein Sci. 2000;9(9):1753–1773. doi: 10.1110/ps.9.9.1753
- Jorgensen W.L., Tirado-Rives J. The OPLS [Optimized Potentials for Liquid Simulations] Potential Functions for Proteins, Energy Minimizations for Crystals of Cyclic Peptides and Crambin. J. Am. Chem. Soc. 1988;110(6):1657–1666. doi: 10.1021/ja00214a001
- Jorgensen W.L. Maxwell D.S., Tirado-Rives J. Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids. J. Am. Chem. Soc. 1996;118(45):11225–11236. doi: 10.1021/ja9621760
- Laskowski R.A., MacArthur M.W., Moss D.S. Thornton J.M. PROCHECK: A Program to Check the Stereochemical Quality of Protein Structures. J. Appl. Crystallogr. 1993;26(2):283–291. doi: 10.1107/S0021889892009944
- Ramachandran G.N., Ramakrishnan C. Sasisekharan V. Stereochemistry of Polypeptide Chain Configurations. J. Mol. Biol. 1963;7(1):95–99. doi: 10.1016/S0022-2836(63)80023-6
- Wiederstein M., Sippl M.J. ProSA-Web: Interactive Web Service for the Recognition of Errors in Three-Dimensional Structures of Proteins. Nucleic Acids Res. 2007;35:W407–W410. doi: 10.1093/nar/gkm290
- Laurie A.T. Methods for the Prediction of Protein-Ligand Binding Sites for Structure-Based Drug Design and Virtual Ligand Screening. Curr. Protein Pept. Sci. 2006;7:395–406. doi: 10.2174/138920306778559386
- Dundas J., Ouyang Z., Tseng J., Binkowski A., Turpaz Y., Liang J. CASTp: Computed Atlas of Surface Topography of Proteins with Structural and Topographical Mapping of Functionally Annotated Residues. Nucleic Acids Res. 2006;34:W116–W118. doi: 10.1093/nar/gkl282
- Laurie A.T.R., Jackson R.M. Q-SiteFinder: An Energy-Based Method for the Prediction of Protein-Ligand Binding Sites. Bioinformatics. 2005;21(9):1908–1916. doi: 10.1093/bioinformatics/bti315
- Halgren T.A. Identifying and Characterizing Binding Sites and Assessing Druggability. J. Chem. Inf. Model. 2009;49(2):377–389. doi: 10.1021/ci800324m
- Goverdhan L., Revanth B., Mahendar D., Manan B., Sarita Rajender P. Identification and optimisation of novel selective inhibitors against human regulator of G protein signalling 2 (RGS2) protein for type 2 diabetes mellitus: an in silico approach. Int. J. Comput. Biol. Drug Des. 2021;14(3):166–189. doi: 10.1504/IJCBDD.2021.10040273
- Navaneetha N., Kiran Kumar M., Vasavi M., Bhargavi K., Sarita Rajender P., Ramasree D., Uma V. Angiogenesis: An Insilico Approach to Angiogenic Phenotype. J. Pharm. Res. 2012;5(1):583–588.
- Schneidman-Duhovny D., Inbar Y., Nussinov R., Wolfson H.J. PatchDock and SymmDock: Servers for Rigid and Symmetric Docking. Nucleic Acids Res. 2005;33:W363–W367. doi: 10.1093/nar/gki481
- Accelrys Discovery Studio Visualiser v 3.5.0.12158. San Diego: Accelrys Software Inc., 2012.
- Ghosh S., Nie A., An J., Huang Z. Structure-Based Virtual Screening of Chemical Libraries for Drug Discovery. Curr. Opin. Chem. Biol. 2006;10(3):194–202. doi: 10.1016/j.cbpa.2006.04.002
- Klebe G. Virtual Ligand Screening: Strategies, Perspectives and Limitations. Drug Discov. Today. 2006;11(13–14):580–594. doi: 10.1016/j.drudis.2006.05.012
- Lengauer T., Rarey M. Computational Methods for Biomolecular Docking. Curr. Opin. Struct. Biol. 1996;6(3):402–406. doi: 10.1016/S0959-440X(96)80061-3
- Lanka G., Bathula R., Bhargavi M., Potlapall S.R. Homology modeling and molecular docking studies for the identification of novel potential therapeutics against human PHD3 as a drug target for type 2 diabetes mellitus. Journal of Drug Delivery and Therapeutics. 2019;9(4):265–273.
- Friesner R.A. Banks J.L. Murphy R.B., Halgren T.A., Klicic J.J., Mainz D.T., Repasky M.P., Knoll E.H., Shelley M., Perry J.K. et al. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy. J. Med. Chem. 2004;47(7):1739–1749. doi: 10.1021/jm0306430
- Kawatkar S., Wang H., Czerminski R., Joseph-McCarthy D. Virtual Fragment Screening: An Exploration of Various Docking and Scoring Protocols for Fragments Using Glide. J. Comput. Aided. Mol. Des. 2009;23(8):527–539. doi: 10.1007/s10822-009-9281-4
- Podvinec M., Lim S.P., Schmidt T., Scarsi M., Wen D., Sonntag L.-S., Sanschagrin P., Shenkin P.S., Schwede T. Novel Inhibitors of Dengue Virus Methyltransferase: Discovery by in Vitro-Driven Virtual Screening on a Desktop Computer Grid. J. Med. Chem. 2010;53(4):1483–1495. doi: 10.1021/jm900776m
- LigPrep, Version 3.3. New York, NY: Schrödinger, LLC, 2010.
- GLIDE, Version 5.6. New York, NY: Schrödinger, LLC, 2010.
- Friesner R.A., Murphy R.B., Repasky M.P., Frye L.L., Greenwood J.R., Halgren T.A., Sanschagrin P.C., Mainz D.T. Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein−Ligand Complexes. J. Med. Chem. 2006;49(21):6177–6196. doi: 10.1021/jm051256o
- Rodrigues A.D. Preclinical Drug Metabolism in the Age of High-Throughput Screening: An Industrial Perspec. Pharm. Res. 1997;14(11):1504–1510. doi: 10.1023/A:1012105713585
- Daina A., Zoete V. A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules. Chem. Med. Chem. 2016;11(11):1117–1121. doi: 10.1002/cmdc.201600182
- Johnson M., Zaretskaya I., Raytselis Y., Merezhuk Y., McGinnis S., Madden T.L. NCBI BLAST: A Better Web Interface. Nucleic Acids Res. 2008;36:W5–W9. doi: 10.1093/nar/gkn201
- Karlin S., Altschul S.F. Methods for Assessing the Statistical Significance of Molecular Sequence Features by Using General Scoring Schemes. Proc. Natl. Acad. Sci. 1990;87(6):2264–2268. doi: 10.1073/pnas.87.6.2264
- Drozdetskiy A., Cole C., Procter J., Barton G.J. JPred4: A Protein Secondary Structure Prediction Server. Nucleic Acids Res. 2015;43(W1):W389–W394. doi: 10.1093/nar/gkv332
- Kerfeld C.A., Scott K.M. Using BLAST to Teach “E-Value-Tionary” Concepts. PLoS Biol. 2011;9(2):e1001014. doi: 10.1371/journal.pbio.1001014
- Wiederstein M., Sippl M.J. ProSA-Web: Interactive Web Service for the Recognition of Errors in Three-Dimensional Structures of Proteins. Nucleic Acids Res. 2007;35:W407–W410. doi: 10.1093/nar/gkm290
- Bergers G., Song S., Meyer-Morse N., Bergsland E., Hanahan D. Benefits of Targeting Both Pericytes and Endothelial Cells in the Tumor Vasculature with Kinase Inhibitors. J. Clin. Invest. 2003;111(9):1287–1295. doi: 10.1172/JCI17929
- Östman A. PDGF Receptors-Mediators of Autocrine Tumor Growth and Regulators of Tumor Vasculature and Stroma. Cytokine Growth Factor Rev. 2004;15(4):275–286. doi: 10.1016/j.cytogfr.2004.03.002
- Erber R., Thurnher A., Katsen A.D., Groth G., Kerger H., Hammes H., Menger M.D., Ullrich A., Vajkoczy P. Combined Inhibition of VEGF- and PDGF-signaling Enforces Tumor Vessel Regression by Interfering with Pericyte-mediated Endothelial Cell Survival Mechanisms. FASEB J. 2004;18(2):338–340. doi: 10.1096/fj.03-0271fje
- Andrae J., Gallini R., Betsholtz C. Role of Platelet-Derived Growth Factors in Physiology and Medicine. Genes Dev. 2008;22(10):1276–1312. doi: 10.1101/gad.1653708
- Fredriksson L., Li H., Fieber C., Li X., Eriksson U. Tissue Plasminogen Activator Is a Potent Activator of PDGF-CC. EMBO J. 2004;23(19):3793–3802. doi: 10.1038/sj.emboj.7600397
- Ritchie T.J., Ertl P., Lewis R. The Graphical Representation of ADME-Related Molecule Properties for Medicinal Chemists. Drug Discov. Today. 2011;16(1–2):65–72. doi: 10.1016/j.drudis.2010.11.002
- Breier A., Gibalova L., Seres M., Barancik M., Sulova Z. New Insight into P-Glycoprotein as a Drug Target. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents). 2013;13(1):159–170. doi: 10.2174/187152013804487380
- Park S.J., Baars H., Mersmann S., Buschmann H., Baron J.M., Amann P.M., Czaja K., Hollert H., Bluhm K., Redelstein R., Bolm C. N -Cyano Sulfoximines: COX Inhibition, Anticancer Activity, Cellular Toxicity, and Mutagenicity. Chem. Med. Chem. 2013;8(2):217–220. doi: 10.1002/cmdc.201200403
|
|
|